Brand Name: SGONEK
Price: $5 -$15/Gram
Place of Origin: Shaanxi, China
Certification: ISO FDA SG COA MSDS
Grade: Feed Grade, Food Grade, Medicine Grade
Payment Terms: T/T, Western Union, MoneyGram
Product Name: | Olanzapine | Cas No.: | 132539-06-1 |
Molecular Formula: | C17H20N4S | Purity: | 99%min |
Brand Name: | SGONEK | Certification: | ISO FDA SG COA MSDS |
Product name: Olanzapine
Other name: 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] Lanzac; Zyprexa
Specification: Standard:Ph.Eur, USP and National Standard
CAS:132539-06-1
Olanzapine is an atypical antipsychotic, approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine, but is classified
Tests |
Standard |
Appearance |
Yellow Crystal Or Crystalline Powder |
Identification |
1. a. The Ir Spectrum Corresponds To Reference Standard 2. b. The Retention Time Of The Major Peak Of The Sample Solution Corresponds To That Of The Standard Solution As Obtained In The Assay |
Related Compounds |
Impurity a≤0.1% Impurity b≤0.1% Chloromethyl Olanzapinium Chloride ≤0.15% Any Individual Unspecified Impurity ≤0.1% Total Impurities ≤0.4% |
Water |
≤1.0% |
Residue On Ignition |
≤0.1% |
Heavy Metals |
≤0.001% |
Residual Solvents |
Ethanol ≤5000ppm Dimethyl Sulfoxide ≤5000ppm Toluene ≤890ppm |
Assay |
98-102.0% |
Medical uses
pharmaceutical Olanzapine
Oral formulation: acute and maintenance treatment of schizophrenia in adults, acute treatment of manic or mixed episodes associated with bipolar I disorder (monotherapy and in combination with lithium or valproate)
Intramuscular formulation like Zyprexa IntraMuscular: acute agitation associated with schizophrenia and bipolar I mania in adults
Oral formulation combined with fluoxetine: treatment of acute depressive episodes associated with bipolar I disorder in adults, or treatment of acute, resistant depression in adults